Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Recent advances in intestinal transplantation have made this treatment option an acceptable clinical reality for many patients with intestinal failure. Growth in this field is closely linked to an improved understanding of the intrinsic immune system of the intestine, and the development of immunosuppression agents that interact with this system. The recent advent of antibody-based immunosuppression induction agents has decreased perioperative rejection episodes and lowered the amount of maintenance immunosuppression required by intestinal transplant patients. As progress is made in lowering the risks of graft rejection, long-term outcomes will continue to improve and a greater number of patients with intestinal failure will benefit from this therapy.

Original languageEnglish (US)
Pages (from-to)293-303
Number of pages11
JournalMinerva Pediatrica
Volume61
Issue number3
StatePublished - 2009
Externally publishedYes

Fingerprint

Immunosuppressive Agents
Immunosuppression
Allografts
Transplantation
Graft Rejection
Intestines
Immune System
Maintenance
Transplants
Antibodies
Therapeutics
Growth

Keywords

  • Graft rejection
  • Immunosuppressive agents
  • Intestinal diseases
  • Transplantation immunology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation. / Vianna, Rodrigo.

In: Minerva Pediatrica, Vol. 61, No. 3, 2009, p. 293-303.

Research output: Contribution to journalArticle

@article{5598e9a2fefc4972bcee0205fd30af69,
title = "Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation",
abstract = "Recent advances in intestinal transplantation have made this treatment option an acceptable clinical reality for many patients with intestinal failure. Growth in this field is closely linked to an improved understanding of the intrinsic immune system of the intestine, and the development of immunosuppression agents that interact with this system. The recent advent of antibody-based immunosuppression induction agents has decreased perioperative rejection episodes and lowered the amount of maintenance immunosuppression required by intestinal transplant patients. As progress is made in lowering the risks of graft rejection, long-term outcomes will continue to improve and a greater number of patients with intestinal failure will benefit from this therapy.",
keywords = "Graft rejection, Immunosuppressive agents, Intestinal diseases, Transplantation immunology",
author = "Rodrigo Vianna",
year = "2009",
language = "English (US)",
volume = "61",
pages = "293--303",
journal = "Minerva Pediatrica",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation

AU - Vianna, Rodrigo

PY - 2009

Y1 - 2009

N2 - Recent advances in intestinal transplantation have made this treatment option an acceptable clinical reality for many patients with intestinal failure. Growth in this field is closely linked to an improved understanding of the intrinsic immune system of the intestine, and the development of immunosuppression agents that interact with this system. The recent advent of antibody-based immunosuppression induction agents has decreased perioperative rejection episodes and lowered the amount of maintenance immunosuppression required by intestinal transplant patients. As progress is made in lowering the risks of graft rejection, long-term outcomes will continue to improve and a greater number of patients with intestinal failure will benefit from this therapy.

AB - Recent advances in intestinal transplantation have made this treatment option an acceptable clinical reality for many patients with intestinal failure. Growth in this field is closely linked to an improved understanding of the intrinsic immune system of the intestine, and the development of immunosuppression agents that interact with this system. The recent advent of antibody-based immunosuppression induction agents has decreased perioperative rejection episodes and lowered the amount of maintenance immunosuppression required by intestinal transplant patients. As progress is made in lowering the risks of graft rejection, long-term outcomes will continue to improve and a greater number of patients with intestinal failure will benefit from this therapy.

KW - Graft rejection

KW - Immunosuppressive agents

KW - Intestinal diseases

KW - Transplantation immunology

UR - http://www.scopus.com/inward/record.url?scp=67749113441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749113441&partnerID=8YFLogxK

M3 - Article

C2 - 19461573

AN - SCOPUS:67749113441

VL - 61

SP - 293

EP - 303

JO - Minerva Pediatrica

JF - Minerva Pediatrica

SN - 0026-4946

IS - 3

ER -